Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Trends: Growth Opportunities
Idiopathic thrombocytopenic purpura (ITP) is a rare autoimmune disorder characterized by low platelet counts, leading to an increased risk of bleeding and bruising. Advances in diagnosis and treatment have significantly improved patient management, creating new opportunities for pharmaceutical manufacturers and … Read more